Widely used:Recently Viewed
Clear All
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$7 Mln
P/E Ratio
--
P/B Ratio
4.71
Industry P/E
--
Debt to Equity
-8.87
ROE
-0.83 %
ROCE
-94.25 %
Div. Yield
0 %
Book Value
--
EPS
-2.75
CFO
$-171.06 Mln
EBITDA
$-192.10 Mln
Net Profit
$-222.47 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Evogene - ADR
| -49.20 | -33.57 | -40.99 | -86.43 | -56.94 | -38.73 | -37.33 |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Evogene - ADR
| 20.00 | -57.32 | -65.11 | 209.21 | -23.23 | -35.35 | -39.80 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 | 11.73 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2.45 | 28.12 | -- | -79.46 | |
| 1.47 | 129.05 | -- | -23.63 | |
| 1.78 | 82.21 | -- | -103.34 | |
| 10.13 | 495.51 | -- | 342.83 |
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries,... including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517 Read more
CEO & President
Mr. Ofer Haviv CPA
CEO & President
Mr. Ofer Haviv CPA
Headquarters
Rehovot
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Evogene Ltd - ADR stood at $ 40 Mln as on 31-Dec-24
The share price of Evogene Ltd - ADR is $0.95 (NASDAQ) as of 17-Apr-2025 12:33 EDT. Evogene Ltd - ADR has given a return of -56.94% in the last 3 years.
Evogene Ltd - ADR has a market capitalisation of $ 7 Mln as on 16-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Evogene Ltd - ADR is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Evogene Ltd - ADR and enter the required number of quantities and click on buy to purchase the shares of Evogene Ltd - ADR.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel. Address: 13 Gad Feinstein Street, Rehovot, Israel, 7638517
The CEO & director of Mr. Ofer Haviv CPA. is Evogene Ltd - ADR, and CFO & Sr. VP is Mr. Ofer Haviv CPA.
There is no promoter pledging in Evogene Ltd - ADR.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
48
|
|
|
15
|
|
|
8
|
|
|
5
|
| Evogene Ltd - ADR | Ratios |
|---|---|
|
Return on equity(%)
|
-310.98
|
|
Operating margin(%)
|
-211.28
|
|
Net Margin(%)
|
-193.69
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Evogene Ltd - ADR was $0 Mln.
$-0.05
(
